PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
17764562-1	2007	INTRODUCTION: 1,1-Bis (3"-indolyl)-1-(p-biphenyl) methane (CDIM9) has been identified as a new peroxisome proliferator-activated receptor (PPAR)-gamma agonist that exhibits both receptor dependent and independent antitumor activities.	cdim9	59-64	peroxisome proliferator activated receptor gamma	Mus musculus	95-150
17764562-7	2007	In MDA-MB231 cell, CDIM9 induced caveolin-1 and p27 expression, which was significantly downregulated by co-treatment with the PPAR-gamma antagonist GW9662.	cdim9	19-24	caveolin 1	Homo sapiens	33-43
17764562-7	2007	In MDA-MB231 cell, CDIM9 induced caveolin-1 and p27 expression, which was significantly downregulated by co-treatment with the PPAR-gamma antagonist GW9662.	cdim9	19-24	interferon alpha inducible protein 27	Homo sapiens	48-51
17764562-7	2007	In MDA-MB231 cell, CDIM9 induced caveolin-1 and p27 expression, which was significantly downregulated by co-treatment with the PPAR-gamma antagonist GW9662.	cdim9	19-24	peroxisome proliferator activated receptor gamma	Homo sapiens	127-137
17764562-12	2007	CDIM9 induced increases in tumor caveolin-1 and p27 in vivo, which may contribute to its antitumor activity in basal-like breast cancer.	cdim9	0-5	caveolin 1, caveolae protein	Mus musculus	33-43
17764562-12	2007	CDIM9 induced increases in tumor caveolin-1 and p27 in vivo, which may contribute to its antitumor activity in basal-like breast cancer.	cdim9	0-5	cyclin-dependent kinase inhibitor 1B	Mus musculus	48-51